Said Sami Erdem
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Said Sami Erdem has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
- Fatih Koc
Kocaeli Üniversitesi
2 shared publications - Hasan Basri Yıldırım
Department of Biochemistry, Konya City Hospital, Konya 42020, Türkiye
2 shared publications Hümeyra Çiçekler
Necmettin Erbakan University, Meram Faculty of Medicine
2 shared publications- Sevil Kurban
Konya University, Meram Medical Faculty, Department of Clinical Biochemistry, Konya, Turkey
2 shared publications A. Annagür
University of Selcuk Meram Faculty of Medicine Department of Neonatalogy, Konya Turkey
1 shared publicationA. Minervini
1 shared publication
Latest Publications
- Open Access
The Diagnostic and Prognostic Value of Reticulated Platelets in Ischemic Stroke: Is Immature Platelet Fraction a New Biomarker?
Background and Objectives: Ongoing efforts to develop early diagnostic tools for Acute Ischemic Stroke (AIS) point out the advantages of accessible biomarkers such as Immature Platelet Fraction (IPF). This is particularly important for emergency department (EDs), especially those that are overcrowded and have limited resources. The present study aimed to evaluate the diagnostic, prognostic, and therapeutic significance of IPF in patients with AIS presenting to the ED. Materials and Methods: This prospective case–control study was conducted in an ED. Participants aged 18-years and older who presented with complaints of numbness, weakness, diplopia or visual disturbances, speech or comprehension impairment, confusion, imbalance, impaired coordination and gait, or dizziness were included in the study. The diagnostic value of IPF in AIS and its relationship with short-term prognosis (STP) were investigated. Additional variables potentially associated with parameters such as infarct localization, number of lesions, affected hemisphere, main artery status, carotid status and treatment method were also analyzed. Results: The median age of the study participants was 67 years (Q1 = 54, Q3 = 76), with 48.9% (n = 88) being female and 51.1% (n = 92) male. Receiver operating characteristic curve analysis demonstrated that IPF was statistically significantly superior to other complete blood count parameters in the diagnostic evaluation of AIS. The diagnostic cutoff value of IPF for AIS was calculated as 2.45. An increase of 1 unit in IPF was found to raise the likelihood of AIS by 2.599 times. The Ratio of Red Cell Distribution Width (RDW) to IPF and NEU to IPF, mean corpuscular volume, and infarct volume were found to be significant predictors in STP assessment. Conclusions: Although not definitive alone, IPF may aid early stroke recognition, support treatment monitoring, and inform targeted therapies. The use of IPF, a biomarker that can be rapidly obtained, in the diagnosis of AIS is expected to yield beneficial outcomes in patient management, particularly in emergency departments and other clinical settings.
Open AccessThe Diagnostic and Prognostic Value of Reticulated Platelets in Ischemic Stroke: Is Immature Platelet Fraction a New Biomarker?
Background and Objectives: Ongoing efforts to develop early diagnostic tools for Acute Ischemic Stroke (AIS) point out the advantages of accessible biomarkers such as Immature Platelet Fraction (IPF). This is particularly important for emergency department (EDs), especially those that are overcrowded and have limited resources. The present study aimed to evaluate the diagnostic, prognostic, and therapeutic significance of IPF in patients with AIS presenting to the ED. Materials and Methods: This prospective case–control study was conducted in an ED. Participants aged 18-years and older who presented with complaints of numbness, weakness, diplopia or visual disturbances, speech or comprehension impairment, confusion, imbalance, impaired coordination and gait, or dizziness were included in the study. The diagnostic value of IPF in AIS and its relationship with short-term prognosis (STP) were investigated. Additional variables potentially associated with parameters such as infarct localization, number of lesions, affected hemisphere, main artery status, carotid status and treatment method were also analyzed. Results: The median age of the study participants was 67 years (Q1 = 54, Q3 = 76), with 48.9% (n = 88) being female and 51.1% (n = 92) male. Receiver operating characteristic curve analysis demonstrated that IPF was statistically significantly superior to other complete blood count parameters in the diagnostic evaluation of AIS. The diagnostic cutoff value of IPF for AIS was calculated as 2.45. An increase of 1 unit in IPF was found to raise the likelihood of AIS by 2.599 times. The Ratio of Red Cell Distribution Width (RDW) to IPF and NEU to IPF, mean corpuscular volume, and infarct volume were found to be significant predictors in STP assessment. Conclusions: Although not definitive alone, IPF may aid early stroke recognition, support treatment monitoring, and inform targeted therapies. The use of IPF, a biomarker that can be rapidly obtained, in the diagnosis of AIS is expected to yield beneficial outcomes in patient management, particularly in emergency departments and other clinical settings.
- Open Access
- 18 January 2024
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 49 (2) , 283-288
Reticulated platelets and coronary slow flow: a study in stable coronary artery disease
Objectives: The coronary slow flow (CSF) phenomenon remains a clinical enigma, characterized by delayed opacification of coronary vessels despite angiographically normal or nearly normal arteries. This cross-sectional study explores the potential relationship between reticulated platelets (RPs) and CSF in stable coronary artery disease patients. Methods: A total of 200 participants, meeting specific inclusion and exclusion criteria, underwent coronary angiography. Reticulated platelet levels were measured using Sysmex series hematology analyzers. Demographic data, laboratory parameters, and coronary flow velocities were assessed. Results: The study comprised 100 individuals with CSF and 100 with normal coronary anatomy. The CSF group exhibited higher rates of diabetes (35 vs. 22 %, p=0.017) and smoking (62 vs. 45 %, p=0.021). Reticulated platelet rates were elevated in the CSF group. However, statistical significance was not reached (p=0.105). Conclusions: This study provides insights into the interplay between reticulated platelets and the CSF phenomenon in stable coronary artery disease. Although reticulated platelet levels did not emerge as a major predictor for CSF in this stable phase, the findings contribute to ongoing efforts to understand the multifaceted mechanisms underlying CSF.
- 18 January 2024
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 49 (2) , 283-288
Open AccessReticulated platelets and coronary slow flow: a study in stable coronary artery disease
Objectives: The coronary slow flow (CSF) phenomenon remains a clinical enigma, characterized by delayed opacification of coronary vessels despite angiographically normal or nearly normal arteries. This cross-sectional study explores the potential relationship between reticulated platelets (RPs) and CSF in stable coronary artery disease patients. Methods: A total of 200 participants, meeting specific inclusion and exclusion criteria, underwent coronary angiography. Reticulated platelet levels were measured using Sysmex series hematology analyzers. Demographic data, laboratory parameters, and coronary flow velocities were assessed. Results: The study comprised 100 individuals with CSF and 100 with normal coronary anatomy. The CSF group exhibited higher rates of diabetes (35 vs. 22 %, p=0.017) and smoking (62 vs. 45 %, p=0.021). Reticulated platelet rates were elevated in the CSF group. However, statistical significance was not reached (p=0.105). Conclusions: This study provides insights into the interplay between reticulated platelets and the CSF phenomenon in stable coronary artery disease. Although reticulated platelet levels did not emerge as a major predictor for CSF in this stable phase, the findings contribute to ongoing efforts to understand the multifaceted mechanisms underlying CSF.
- Open Access
- 9 September 2023
- Published by Pera Yayıncılık Hizmetleri in European Journal of Therapeutics
- Vol. 29 (4) , 856-865
Plasma Leptin, Nesfatin 1, NPY, and Zinc Levels in Obese and Metabolic Syndrome Children
Objective: The aim of this study is to investigate the relationship between leptin, nesfatin 1 and NPY hormones and zinc in boys and girls diagnosed with metabolic syndrome and obesity. Materials and Methods: This study included a total of 6 groups. Group 1 Boy Control, Group 2 Girl Control, Group 3 Obese Boys, Group 4 Obese Girls, Group 5 Boys with Metabolic Syndrome, Group 2 with Girls with Metabolic Syndrome. Plasma leptin, nesfatin-1, NPY (by ELISA method) and serum zinc (by AA method) levels were determined in blood samples obtained from the subjects. Results: Leptin and zinc levels were significantly higher both in boy and girl patients with metabolic syndrome than in obese and control children. Nesfatin-1 and NPY levels were significantly lower both in girl and boy obese and metabolic syndrome children compared to their control groups. Conclusion: In the current study a significant increase in plasma leptin and serum zinc levels and a significant decrease of plasma nesfatin-1 and NPY levels were observed in boys and girls with metabolic syndrome. The findings of our study show that leptin, nesfatin-1 and NPY levels may be important biomarkers in the assessment of metabolic syndrome risk in both girls and boys.
- 9 September 2023
- Published by Pera Yayıncılık Hizmetleri in European Journal of Therapeutics
- Vol. 29 (4) , 856-865
Open AccessPlasma Leptin, Nesfatin 1, NPY, and Zinc Levels in Obese and Metabolic Syndrome Children
Objective: The aim of this study is to investigate the relationship between leptin, nesfatin 1 and NPY hormones and zinc in boys and girls diagnosed with metabolic syndrome and obesity. Materials and Methods: This study included a total of 6 groups. Group 1 Boy Control, Group 2 Girl Control, Group 3 Obese Boys, Group 4 Obese Girls, Group 5 Boys with Metabolic Syndrome, Group 2 with Girls with Metabolic Syndrome. Plasma leptin, nesfatin-1, NPY (by ELISA method) and serum zinc (by AA method) levels were determined in blood samples obtained from the subjects. Results: Leptin and zinc levels were significantly higher both in boy and girl patients with metabolic syndrome than in obese and control children. Nesfatin-1 and NPY levels were significantly lower both in girl and boy obese and metabolic syndrome children compared to their control groups. Conclusion: In the current study a significant increase in plasma leptin and serum zinc levels and a significant decrease of plasma nesfatin-1 and NPY levels were observed in boys and girls with metabolic syndrome. The findings of our study show that leptin, nesfatin-1 and NPY levels may be important biomarkers in the assessment of metabolic syndrome risk in both girls and boys.
- Open Access
- 14 October 2021
- Published by Lycia Press London UK in Medical Science and Discovery
- Vol. 8 (10) , 581-585
Can changes in platelet count, mean platelet volume, and platelet distribution width be used to determine the severity of COVID-19?
Objective: We aimed to investigate the relation of platelet count (PLT), mean platelet volume (MPV) and platelet distribution width (PDW) with other acute phase reactants in COVID-19 new corona virus. Material and Methods: Thirty one patients with COVID-19 were included in to study. There were three groups as outpatient (Group 1, OP)(n=6), hospital (Group 2, H)(n=16) and intensive care unit (Group 3, IC)(n=9) in this analytic study. Results: WBC (White Blood Cell), CRP (C-Reactive Protein) values were significantly different in all groups. PDW values were significantly lower in Group 3 than Group 1, 2. The result of ROC analysis was 10.9 as a cut-off value (Area under the curve, AUC)=0.407) Conclusions: This study indicates that lower PDW may frequently develop in COVID-19 cases and there is a relation between thrombocytosis and acute phase reactants, that is, the inflammatory response. So we can offer that PDW should be used as a marker of Covid-19 disease severity, but it needs more studies in the future.
- 14 October 2021
- Published by Lycia Press London UK in Medical Science and Discovery
- Vol. 8 (10) , 581-585
Open AccessCan changes in platelet count, mean platelet volume, and platelet distribution width be used to determine the severity of COVID-19?
Objective: We aimed to investigate the relation of platelet count (PLT), mean platelet volume (MPV) and platelet distribution width (PDW) with other acute phase reactants in COVID-19 new corona virus. Material and Methods: Thirty one patients with COVID-19 were included in to study. There were three groups as outpatient (Group 1, OP)(n=6), hospital (Group 2, H)(n=16) and intensive care unit (Group 3, IC)(n=9) in this analytic study. Results: WBC (White Blood Cell), CRP (C-Reactive Protein) values were significantly different in all groups. PDW values were significantly lower in Group 3 than Group 1, 2. The result of ROC analysis was 10.9 as a cut-off value (Area under the curve, AUC)=0.407) Conclusions: This study indicates that lower PDW may frequently develop in COVID-19 cases and there is a relation between thrombocytosis and acute phase reactants, that is, the inflammatory response. So we can offer that PDW should be used as a marker of Covid-19 disease severity, but it needs more studies in the future.
- 27 May 2021
- Published by Dokuz Eyul Universitesi Saglik Bilimleri Enstitusu in Journal of Basic and Clinical Health Sciences
- Vol. 5 (2) , 59-64
The Evaluation of Ischemia Modified Albumin and Adropin Levels in Patients with Pulmonary Embolism
Background: Pulmonary embolism (PE) is a serious clinical condition and difficult to be diagnosed. The aim of the present study was to evaluate serum adropin and ischemia-modified albumin (IMA) levels in the patients with PE. Materials and Methods: The study consisted of 109 participants, including 50 patients with PE and 59 healthy individuals. The patients diagnosed with PE through computed tomography pulmonary angiography (CTPA) were included into the study. Serum adropin and IMA concentrations were measured by an enzyme-linked immunosorbent assay kit. Results: The patients with PE had higher serum adropin (607.5±205.1 ng/mL) and lower IMA (2128.6±801.8 ng/mL), compared with those in the controls (505.5±231.3 ng/mL and 2466.9±1044.9 ng/mL, respectively); however, the difference was not significant. In the study, we found a weak and negative correlation between adropin and IMA levels in the patients with PE (p=0.020, r=-0.348). Conclusions: In our study among the patients with PE, there was no significant difference between adropin and IMA levels, although serum atropin concentration was high, and IMA concentration was low. So, we consider that both IMA and adropin are the inappropriate markers for the diagnosis of PE.
- 27 May 2021
- Published by Dokuz Eyul Universitesi Saglik Bilimleri Enstitusu in Journal of Basic and Clinical Health Sciences
- Vol. 5 (2) , 59-64
The Evaluation of Ischemia Modified Albumin and Adropin Levels in Patients with Pulmonary Embolism
Background: Pulmonary embolism (PE) is a serious clinical condition and difficult to be diagnosed. The aim of the present study was to evaluate serum adropin and ischemia-modified albumin (IMA) levels in the patients with PE. Materials and Methods: The study consisted of 109 participants, including 50 patients with PE and 59 healthy individuals. The patients diagnosed with PE through computed tomography pulmonary angiography (CTPA) were included into the study. Serum adropin and IMA concentrations were measured by an enzyme-linked immunosorbent assay kit. Results: The patients with PE had higher serum adropin (607.5±205.1 ng/mL) and lower IMA (2128.6±801.8 ng/mL), compared with those in the controls (505.5±231.3 ng/mL and 2466.9±1044.9 ng/mL, respectively); however, the difference was not significant. In the study, we found a weak and negative correlation between adropin and IMA levels in the patients with PE (p=0.020, r=-0.348). Conclusions: In our study among the patients with PE, there was no significant difference between adropin and IMA levels, although serum atropin concentration was high, and IMA concentration was low. So, we consider that both IMA and adropin are the inappropriate markers for the diagnosis of PE.
- Open Access
- 1 July 2020
- Published by Elsevier in European Urology Open Science
- Vol. 19, e1268-e1269
Predictors for perioperative complications in cytoreductive nephrectomy: Analysis of the registry for metastatic RCC (REMARCC)
- 1 July 2020
- Published by Elsevier in European Urology Open Science
- Vol. 19, e1268-e1269
Open AccessPredictors for perioperative complications in cytoreductive nephrectomy: Analysis of the registry for metastatic RCC (REMARCC)
- 22 May 2014
- Published by Springer Nature in International Journal of Diabetes in Developing Countries
- Vol. 35 (S3) , 465-470
Oxidant and antioxidant parameters in prediabetes and diabetes
- 22 May 2014
- Published by Springer Nature in International Journal of Diabetes in Developing Countries
- Vol. 35 (S3) , 465-470
Oxidant and antioxidant parameters in prediabetes and diabetes
- Open Access
- 9 April 2013
- Published by Modestum Ltd in Electronic Journal of General Medicine
- Vol. 10 (2) , 90-95
Asymmetric Dimethylarginine and Homocysteine Levels in Dialysis Patients
Cardiovascular diseases and endothelial disfunction are major causes of mortality in patients with end stage renal disease (ESRD). Treatment strategies like continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis (HD) have different effects on different parameters. Asymmetric...
- 9 April 2013
- Published by Modestum Ltd in Electronic Journal of General Medicine
- Vol. 10 (2) , 90-95
Open AccessAsymmetric Dimethylarginine and Homocysteine Levels in Dialysis Patients
Cardiovascular diseases and endothelial disfunction are major causes of mortality in patients with end stage renal disease (ESRD). Treatment strategies like continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis (HD) have different effects on different parameters. Asymmetric...
- Open Access
- 1 September 2011
- Published by AVES YAYINCILIK A.Ş. in Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
- Vol. 11 (7) , 582-7
Ischemia-modified albumin and total antioxidant status in patients with slow coronary flow: a pilot observational study
Anadolu Kardiyoloji Dergisi, Anadolu Kardiyol Derg, The Anatolian Journal of Cardiology, Anatol J Cardiol, Cardiology, Cardiovascular Medicine, Surgery, Pediatric Cardiology, Angiology
- 1 September 2011
- Published by AVES YAYINCILIK A.Ş. in Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
- Vol. 11 (7) , 582-7
Open AccessIschemia-modified albumin and total antioxidant status in patients with slow coronary flow: a pilot observational study
Anadolu Kardiyoloji Dergisi, Anadolu Kardiyol Derg, The Anatolian Journal of Cardiology, Anatol J Cardiol, Cardiology, Cardiovascular Medicine, Surgery, Pediatric Cardiology, Angiology